0001757073-23-000068.txt : 20231002 0001757073-23-000068.hdr.sgml : 20231002 20231002164929 ACCESSION NUMBER: 0001757073-23-000068 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230922 FILED AS OF DATE: 20231002 DATE AS OF CHANGE: 20231002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Keller Stephen CENTRAL INDEX KEY: 0001993880 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39054 FILM NUMBER: 231300374 MAIL ADDRESS: STREET 1: 200 S. KRAEMER BLVD. STREET 2: BUILDING E CITY: BREA STATE: CA ZIP: 92821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Envista Holdings Corp CENTRAL INDEX KEY: 0001757073 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] IRS NUMBER: 832206728 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 S. KRAEMER BLVD., BLDG. E CITY: BREA STATE: CA ZIP: 92821 BUSINESS PHONE: 714-817-5418 MAIL ADDRESS: STREET 1: 200 S. KRAEMER BLVD., BLDG. E CITY: BREA STATE: CA ZIP: 92821 FORMER COMPANY: FORMER CONFORMED NAME: DH Dental Holding Corp. DATE OF NAME CHANGE: 20181025 3 1 wk-form3_1696279754.xml FORM 3 X0206 3 2023-09-22 0 0001757073 Envista Holdings Corp NVST 0001993880 Keller Stephen C/O ENVISTA HOLDINGS CORPORATION 200 S. KRAEMER BLVD., BLDG. E BREA CA 92821 0 1 0 0 Principal Financial Officer Common Stock 2562 D Common Stock 1700 D Common Stock 990 D Common Stock 794 D Common Stock 1547 D Common Stock 207 D Common Stock 3270 D Employee Stock Option (Right to Buy) 26.50 2030-02-25 Common Stock 15680 D Employee Stock Option (Right to Buy) 38.25 2033-02-25 Common Stock 7850 D Employee Stock Option (Right to Buy) 37.94 2031-02-25 Common Stock 11130 D Employee Stock Option (Right to Buy) 48.52 2032-02-25 Common Stock 6470 D Envista deferred contribution programs - Envista Stock Fund Common Stock 1211 D Consists of Restricted Stock Units ("RSU") that will vest as to 850 shares on each of February 25, 2024 and 2025, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Consists of RSUs that will vest as to 990 shares on February 25, 2024, subject to continued service through such date. Consists of RSUs that will vest as to 794 shares on August 25, 2024, subject to continued service through such date. Consists of RSUs that will vest as to 773 shares on February 25, 2024 and 774 shares on February 25, 2025, subject to continued service through each such date. Consists of RSUs that will vest as to 103 shares on February 25, 2024 and 104 shares on February 25, 2025, subject to continued service through each such date. Consists of RSUs that were granted on February 25, 2023 and will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. This Option will vest as to 3,136 shares on each of February 25, 2024 and February 2025, subject to continued service through each such date. The remainder of the Option is fully vested. This Option will vest as to 2,616 shares on February 25, 2024 and 2,617 shares on each of February 25, 2025 and 2026, subject to continued service through each such date. This Option will vest as to 3,710 shares on February 25, 2024, subject to continued service through such date. The remainder of the Option is fully vested. This Option will vest as to 2,157 shares on each of February 25, 2024 and 2025, subject to continued service through each such date. The remainder of the Option is fully vested. Consists of shares attributable to the participant's Envista Deferred Contribution Plan ("DCP") account and Envista Excess Contribution Program ("ECP") account. The incremental number of notional phantom shares of Common Stock credited to the participant's DCP or ECP account is based on the incremental amount of contribution to the participant's DCP or ECP account balance divided by the closing price of Common Stock as reported on the NYSE on the date of the contribution. The types of contributions, vesting terms and manner and form of distribution of amounts contributed or deferred under the DCP or ECP are based upon the provisions of the respective plan, which provisions are summarized in the latest Envista Holdings Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission. /s/ Heather L. Turner, By POA from Stephen Keller 2023-10-02 EX-24 2 poa-stephenkeller.htm EX-24 Document

Exhibit 24

POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints each of Mark Nance and Heather L. Turner or any of them signing singly, and with full power of substitution, the undersigned's true and lawful attorney-in-fact to:

(1) prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC;

(2) execute for and on behalf of the undersigned, in the undersigned's capacity as an employee or officer of Envista Holdings Corporation, a Delaware corporation (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(3) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and file any such Form or amendment with the SEC and any stock exchange or similar authority, including filing this Power of Attorney with the SEC; and

(4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.




This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 14 day of September 2023.

/s/ Stephen Keller
Stephen Keller